Structural characteristics of 5-HT1A receptors and their ligands

Pharmacochemistry Library

Volumn 27, Issue C, 1997, Pages 45-64

  Kuipers, W ^a  

^a Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957037876     PISSN: 01657208     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0165-7208(97)80004-9     Document Type: Article

References (59)

1. Savarese T.M., and Fraser C.M. Biochem J 283 (1992) 1-19
2. Lee N.H., and Kerlavage N.R. Tr Biomed Res 6 (1993) 488-497
3. Strader C.D., Fong T.M., Tota M.R., and Underwood D. Ann Rev Biochem 63 (1994) 101-132
4. Schwartz T. Curr Opinion Biotech 5 (1994) 434-444
5. Ho B.Y., Karschin A., Branchek T., Davidson N., et al. FEBS Lett 312 (1992) 259-262
6. Chanda P.K., Minchin M.C.W., Davis A.R., Greenberg L., et al. Mol Pharmacol 43 (1993) 516-520
7. Horstman D.A., Brandon S., Wilson A.L., Guyer C.A., et al. J Biol Chem 35 (1990) 21590-21595
8. Neve K.A., Cox B.A., Henningsen R.A., Spanoyannis A., et al. Mol Pharmacol 39 (1991) 733-739
9. Oliveira L., Paiva A., Sander C., and Vriend G. TIPS 15 (1994) 170-172
10. Dixon R., Sigal I.S., Candelore M.R., Register R.B., et al. EMBO J 6 (1987) 3269-3275
11. Karnik S.S., and Khorona H.G. J Biol Chem 265 (1990) 17520-17524
12. Savarese T.M., Wang C.D., and Fraser C.M. J Biol Chem 267 (1992) 11439-11448
13. Henderson R., Baldwin J.M., Ceska T.A., Zemlin D., et al. J Mol Biol 213 (1990) 899-929
14. Heijne von G. J Mol Biol 218 (1991) 499-503
15. Trumpp-Kallmeyer S., Hoflack J., Bruinvels A., and Hibert M. J Med Chem 35 (1992) 3448-3462
16. Zhou W., Flanagan C., Ballesteros J.A., Konvicka K., et al. Mol Pharmacol 45 (1994) 165-170
17. Sealfon S.C., Chi L., Ebersole B.J., Rodic V., et al. J Biol Chem 270 (1995) 16683-16688
18. Raymond J.R. J Biol Chem 266 (1991) 14747-14753
19. Strader C.D., Sigal I.S., and Dixon R. FASEB J 3 (1989) 1825-1832
20. Choudhary M.S., Graigo S., and Roth B.L. Mol Pharmacol 43 (1993) 755-761
21. Guan X., Peroutka S.J., and Kobilka B.K. Mol Pharmacol 41 (1992) 695-698
22. Suryanarayana S., Daunt D.A., Zastrow M.v., and Kobilka B.K. J Biol Chem 266 (1991) 15488-15492
23. Oksenberg D., Marsters S.A., O'Dowd B.F., Jin H., et al. Nature 360 (1992) 161-163
24. Metcalf M.A., McGuffin R.W., and Hamblin M.W. Biochem Pharmacol 44 (1992) 1917-1920
25. Adham N., Tamm J.A., Salon J.A., Vaysse P.J.J., et al. Neuropharmacol 33 (1994) 387-391
26. Kobilka B.K., Frielle T., Collins S., Yang-Feng T., et al. Nature 329 (1987) 75-79
27. Fargin A., Raymond J.R., Lohse M.J., Kobilka B.K., et al. Nature 335 (1988) 358-360
28. Albert P.R., Zhou Q., Tol H.v., Bunzow J.R., et al. J Biol Chem 265 (1990) 5825-5832
29. Fujiwara Y., Nelson D.L., Kahsihara K., Varga E., et al. Life Sci 47 (1990) 127-132
30. Peroutka S.J. Synapse 18 (1994) 241-260
31. Oakey R.J., Caron M.G., Lefkowitz R.J., and Seldin M.F. Genomics 10 (1991) 338-344
32. Strader C.D., Candelore M.R., Hill W.S., Dixon R., et al. J Biol Chem 264 (1989) 16470-16477
33. Hibert M., Trumpp-Kallmeyer S., Hoflack J., and Bruinvels A. TIPS 14 (1993) 7-12
34. Hibert M.F., McDermott I., Middlemiss D.N., et al. Eur J Med Chem 24 (1989) 31-37
35. Mellin C., Vallgarda J., Nelson D.L., et al. J Med Chem 34 (1991) 497-510
36. Chidester C.G., Lin C.-H., Lahti R.A., et al. J Med Chem 36 (1993) 1301-1315
37. Jain A.N., Harris N.L., and Park J.Y. J Med Chem 38 (1995) 1295-1308
38. Westkaemper R.B., and Glennon R.A. Pharmacol Biochem Behav 40 (1991) 1019-1031
39. Hacksell U., Liu Y., et al. Drug Design Disc 9 (1993) 287-297
40. Björk L., Backlund B., Höök, et al. J Med Chem 32 (1989) 779-783
41. Mellin C., Björk L., Karlén A., et al. J Med Chem 31 (1988) 1130-1140
42. Wikström H., Andersson B., et al. J Med Chem 30 (1987) 1567-1573
43. Arvidsson L.E., Johansson A.M., et al. J Med Chem 30 (1987) 2105-2109
44. Moon M.W., Morris J.K., Heier R.F., et al. J Med Chem 35 (1992) 1076-1092
45. Glennon R.A., Naimann N.A., Pierson M.E., Smith J.D., et al. J Med Chem 32 (1989) 1921-1926
46. Taylor E.W., Nikam S.S., Lambert G., Martin A.R., et al. Mol Pharmacol 34 (1988) 42-53
47. Glennon R.A. Drug Dev Res 26 (1992) 251-274
48. Sleight A.J., and Peroutka S.J. Naunyn-Schmiedeberg's Arch Pharmacol 343 (1991) 109-116
49. Kuipers W., Van Wijngaarden I., Kruse C.G., Ter Horst-Van Amstel M., et al. J Med Chem 38 (1995) 1942-1954
50. Baldwin J.M. EMBO J 12 (1992) 1693-1703
51. Trumpp-Kallmeyer S., Bruinvels A., Hoflack J., et al. Neurochem Int 19/4 (1991) 397-406
52. Kuipers W., Van Wijngaarden I., and IJzerman A.P. Drug Design Disc 11 (1994) 231-249
53. Glennon R.A., Titeler M., Lyon R.A., and Slusher R.M. J Med Chem 31 (1988) 867-870
54. Slaughter J.L., Harrington M.A., and Peroutka S.J. Life Sci 47 (1990) 1331-1337
55. Hedberg M.H., Johansson A.M., Nordvall G., Yliniemelä A., et al. J Med Chem 38 (1995) 647-658
56. Hoyer D. In: Fozard J.R. (Ed). The peripheral actions of 5-hydroxytryptamine (1989), Oxford University Press, New York 72-99
57. Macor J.E., Fox C.B., Johnson C., Koe K., et al. J Med Chem 35 (1992) 3625-3632
58. Hibert M.F., Gittos M.W., Middlemiss D.N., et al. J Med Chem 31 (1988) 1087-1093
59. Langlois M., Brémont B., Rouselle D., et al. Eur J Pharm-Mol Pharm Sec 244 (1993) 77-87